BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 32848702)

  • 1. Decreased Deposition of Beta-Amyloid 1-38 and Increased Deposition of Beta-Amyloid 1-42 in Brain Tissue of Presenilin-1 E280A Familial Alzheimer's Disease Patients.
    Dinkel F; Trujillo-Rodriguez D; Villegas A; Streffer J; Mercken M; Lopera F; Glatzel M; Sepulveda-Falla D
    Front Aging Neurosci; 2020; 12():220. PubMed ID: 32848702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deposition of hyperphosphorylated tau in cerebellum of PS1 E280A Alzheimer's disease.
    Sepulveda-Falla D; Matschke J; Bernreuther C; Hagel C; Puig B; Villegas A; Garcia G; Zea J; Gomez-Mancilla B; Ferrer I; Lopera F; Glatzel M
    Brain Pathol; 2011 Jul; 21(4):452-63. PubMed ID: 21159009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.
    Sepulveda-Falla D; Barrera-Ocampo A; Hagel C; Korwitz A; Vinueza-Veloz MF; Zhou K; Schonewille M; Zhou H; Velazquez-Perez L; Rodriguez-Labrada R; Villegas A; Ferrer I; Lopera F; Langer T; De Zeeuw CI; Glatzel M
    J Clin Invest; 2014 Apr; 124(4):1552-67. PubMed ID: 24569455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMY plaques in familial AD: comparison with sporadic Alzheimer's disease.
    Lippa CF; Schmidt ML; Nee LE; Bird T; Nochlin D; Hulette C; Mori H; Lee VM; Trojanowski JQ
    Neurology; 2000 Jan; 54(1):100-4. PubMed ID: 10636133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The E280A presenilin 1 Alzheimer mutation produces increased A beta 42 deposition and severe cerebellar pathology.
    Lemere CA; Lopera F; Kosik KS; Lendon CL; Ossa J; Saido TC; Yamaguchi H; Ruiz A; Martinez A; Madrigal L; Hincapie L; Arango JC; Anthony DC; Koo EH; Goate AM; Selkoe DJ; Arango JC
    Nat Med; 1996 Oct; 2(10):1146-50. PubMed ID: 8837617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer's disease.
    Sepulveda-Falla D; Chavez-Gutierrez L; Portelius E; Vélez JI; Dujardin S; Barrera-Ocampo A; Dinkel F; Hagel C; Puig B; Mastronardi C; Lopera F; Hyman BT; Blennow K; Arcos-Burgos M; de Strooper B; Glatzel M
    Acta Neuropathol; 2021 Feb; 141(2):217-233. PubMed ID: 33319314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebellar pathology in sporadic and familial Alzheimer's disease including APP 717 (Val-->Ile) mutation cases: a morphometric investigation.
    Fukutani Y; Cairns NJ; Rossor MN; Lantos PL
    J Neurol Sci; 1997 Aug; 149(2):177-84. PubMed ID: 9171327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subjects harboring presenilin familial Alzheimer's disease mutations exhibit diverse white matter biochemistry alterations.
    Roher AE; Maarouf CL; Malek-Ahmadi M; Wilson J; Kokjohn TA; Daugs ID; Whiteside CM; Kalback WM; Macias MP; Jacobson SA; Sabbagh MN; Ghetti B; Beach TG
    Am J Neurodegener Dis; 2013; 2(3):187-207. PubMed ID: 24093083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence For and Against a Pathogenic Role of Reduced γ-Secretase Activity in Familial Alzheimer's Disease.
    Jayne T; Newman M; Verdile G; Sutherland G; Münch G; Musgrave I; Moussavi Nik SH; Lardelli M
    J Alzheimers Dis; 2016 Apr; 52(3):781-99. PubMed ID: 27060961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E280A presenilin mutation reduces voltage-gated sodium channel levels in neuronal cells.
    Kim DY; Wertz MH; Gautam V; D'Avanzo C; Bhattacharyya R; Kovacs DM
    Neurodegener Dis; 2014; 13(2-3):64-68. PubMed ID: 24217025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Precursor-Independent Overproduction of Beta-Amyloid in AD: Mitochondrial Dysfunction as Possible Initiator of Asymmetric RNA-Dependent βAPP mRNA Amplification. An Engine that Drives Alzheimer's Disease.
    Volloch V; Olsen BR; Rits S
    Ann Integr Mol Med; 2019; 1(1):61-74. PubMed ID: 31858090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of beta amyloid independent small vessel disease in familial Alzheimer's disease.
    Littau JL; Velilla L; Hase Y; Villalba-Moreno ND; Hagel C; Drexler D; Osorio Restrepo S; Villegas A; Lopera F; Vargas S; Glatzel M; Krasemann S; Quiroz YT; Arboleda-Velasquez JF; Kalaria R; Sepulveda-Falla D
    Brain Pathol; 2022 Nov; 32(6):e13097. PubMed ID: 35695802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha-secretase-derived product of beta-amyloid precursor protein is decreased by presenilin 1 mutations linked to familial Alzheimer's disease.
    Ancolio K; Marambaud P; Dauch P; Checler F
    J Neurochem; 1997 Dec; 69(6):2494-9. PubMed ID: 9375682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Familial Alzheimer's disease presenilin 1 mutations cause alterations in the conformation of presenilin and interactions with amyloid precursor protein.
    Berezovska O; Lleo A; Herl LD; Frosch MP; Stern EA; Bacskai BJ; Hyman BT
    J Neurosci; 2005 Mar; 25(11):3009-17. PubMed ID: 15772361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Presenilin Mutations on APP Cleavage; Insights into the Pathogenesis of FAD.
    Li N; Liu K; Qiu Y; Ren Z; Dai R; Deng Y; Qing H
    Front Aging Neurosci; 2016; 8():51. PubMed ID: 27014058
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatial patterns of β-amyloid (Aβ) deposits in familial and sporadic Alzheimer's disease.
    Armstrong RA
    Folia Neuropathol; 2011; 49(3):153-61. PubMed ID: 22101948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.